MARK4 and Alzheimer disease: PAR-1 also phosphorylates Tau at the S262 and S356 residues, as its homolog MARK4 does, which is implicated in Alzheimer’s disease-related tau toxicity (Nishimura et al., 2004; Ando et al., 2016).